Cargando…
LncRNA PVT1 Acts as a Tumor Promoter in Thyroid Cancer and Promotes Tumor Progression by Mediating miR-423-5p-PAK3
INTRODUCTION: Thyroid cancer (TC) is an endocrine tumor whose risk of onset has been rising, so the deep understanding of its molecular mechanism helps formulate new treatment strategies. METHODS: This paper was aimed at exploring the regulatory mechanism of long non-coding RNA (LncRNA) plasmacytoma...
Autores principales: | Lin, Qiu-Yu, Qi, Qian-Le, Hou, Sen, Chen, Zhen, Zhang, Laney, Zhao, Hong-Guang, Lin, Cheng-He |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779291/ https://www.ncbi.nlm.nih.gov/pubmed/33408513 http://dx.doi.org/10.2147/CMAR.S283443 |
Ejemplares similares
-
LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214
por: Chen, Ying, et al.
Publicado: (2018) -
Noncoding RNA PVT1 in osteosarcoma: The roles of lncRNA PVT1 and circPVT1
por: Wu, Tingrui, et al.
Publicado: (2022) -
Down-regulation of miR-203a by lncRNA PVT1 in multiple myeloma promotes cell proliferation
por: Yang, Man, et al.
Publicado: (2018) -
LncRNA PVT1 Promotes Hypoxia-Induced Cardiomyocyte Injury by Inhibiting miR-214-3p
por: Liu, Chuanliang, et al.
Publicado: (2021) -
miR-423 sponged by lncRNA NORHA inhibits granulosa cell apoptosis
por: Li, Yuqi, et al.
Publicado: (2023)